View of NEW NLRP3 INHIBITORS IN THE TREATMENT OF ATHEROSCLEROSIS AND HEART FAILURE WITH PRESERVED EJECTION FRACTION

Return to Article Details NEW NLRP3 INHIBITORS IN THE TREATMENT OF ATHEROSCLEROSIS AND HEART FAILURE WITH PRESERVED EJECTION FRACTION Download Download PDF